Gene Mack, CFO and Interim CEO: Gain Therapeutics GANX Buy · Filed 24/08/12

Trade details

Type: Insider buy
Amount: $14,544
Shares · price: 14,400 sh · $1.01 a share
Held after: 14,400 sh
Stock: Gain Therapeutics GANX
Person: Gene MackCFO and Interim CEO
Trade date: 24/08/09
Filed: 24/08/12
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 2 insiders

Gain Therapeutics trades, last 26 weeks

What else happened in Gain Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/10~24/09/08

Gene Mack's recent trades

No other trades yet.